No
Yes
View More
View Less
Working...
Close
OK
Cancel
Confirm
System Message
Delete
Schedule
An unknown error has occurred and your request could not be completed. Please contact support.
Scheduled
Wait Listed
Personal Calendar
Speaking
Conference Event
Meeting
Interest
Schedule TBD
Conflict Found
This session is already scheduled at another time. Would you like to...
Loading...
Please enter a maximum of {0} characters.
Please enter a maximum of {0} words.
must be 50 characters or less.
must be 40 characters or less.
Session Summary
We were unable to load the map image.
This has not yet been assigned to a map.
Search Catalog
Reply
Replies ()
Search
New Post
Microblog
Microblog Thread
Post Reply
Post
Your session timed out.
This web page is not optimized for viewing on a mobile device. Visit this site in a desktop browser to access the full set of features.
2017 GTC San Jose

John Baldoni

Sr. VP, Platform Technology & Science, GSK Pharmaceuticals

Speaker Bio

John Baldoni is senior vice president of Platform Technology and Science at GSK Pharma R&D. PTS spans the entire spectrum of drug discovery and development, contributing to target characterization and pre-candidate selection through commercial launch and life-cycle management of marketed medicines. Working in partnership with pipeline owners, PTS conducts a range of major activities, including provision of materials and knowledge needed to test the potential of a molecule in early drug discovery; assessment of risks associated with candidate molecules using in vitro and non-clinical models; and provision of the chemistry, formulation, and manufacture of the physical drug product for global manufacturing and supply. These accountabilities cover the pharmaceutical pipeline of small molecules, biopharmaceuticals, and cell and gene therapies. In addition to these activities, PTS is a key contributor to the modernization of R&D.

Speaker Sessions